This note demonstrates how using HTRF to quantify human IFN-β is a powerful and effective method for the characterization of STING agonists.
It provides data demonstrating that the quantification of IFN-β using HTRF is well correlated with ELISA assays.
This note also provides data about gene reporter assay correlation with our HTRF IFN-β assay.
We are committed to your privacy. Revvity needs the contact information you provide us to keep you aware about relevant content, products, and services. You may unsubscribe from these communications at any time. For more information check out our Privacy Policy.
©2023 Revvity - All rights reserved